Wall Street JournalSig. 4NewsEnergyEconomyTrade
European natural gas prices rose about 3% in early trading as thin EU storage levels and stalled U.S.-Iran talks raised winter supply concerns. Inventories stand at 70% versus a seasonal average of 86%, with lower Norwegian pipeline flows offsetting higher LNG arrivals.
Fox NewsSig. 5NewsTradeEconomyForeign
Treasury Secretary Scott Bessent announced on Fox News that the U.S. and China agreed to extend their Busan trade truce until January 10, giving both sides more time to negotiate economic issues. The segment also touched on Iran and AI.
Daily MailSig. 7NewsPoliticsForeignTrade
Andy Burnham refused to rule out making EU rejoin a Labour manifesto pledge while prioritizing a stalled UK-EU reset, and he blamed Brexit on outside actors manipulating opinion. The report also highlights UK concerns over EU protectionism ahead of his talks with Ursula von der Leyen.
New York PostSig. 5NewsTradeEconomy
A large family-run California vineyard is selling 3,500 acres across 11 properties after Canadian provinces banned US alcohol imports in retaliation for Trump tariffs. The sale reflects broader turmoil in the wine industry from falling consumption, rising costs, and excess inventory.
The HillSig. 7NewsTradeEconomyForeign
Treasury Secretary Scott Bessent said U.S. and Chinese officials are considering lowering tariffs on about $30 billion in noncritical goods each country imports, ahead of a planned Trump-Xi meeting in Washington. U.S. Trade Representative Jamieson Greer described recent talks as positive but accused China of limiting rare earth exports. The report also notes the declining U.S. trade deficit with China.
Washington ExaminerSig. 6NewsTradeEconomyPolitics
President Trump announced the US is negotiating a deal to buy potash fertilizer from Belarus as a trade war with Canada raises costs for farmers and ranchers. The report notes political pressure ahead of the midterms and prior administration steps to ease agricultural prices.
New York PostSig. 8NewsAIForeignTrade
The US proposed an AI notification exchange system with China during talks ahead of the UN General Assembly, modeled on the Cold War Washington-Moscow hotline. The two sides did not extend their trade truce, which expires in November, and Trump is set to host Xi Jinping for a state visit later in the week.
Washington ExaminerSig. 5OpinionTradePoliticsForeign
An op-ed argues that President Trump should press Asian countries for reciprocal fair market access, citing a poll showing 78% of voters support action. It praises recent trade agreements with Indonesia, Japan, and South Korea and urges follow-through at UNGA and G20 meetings.
The HillSig. 6NewsForeignTradeAI
Treasury Secretary Scott Bessent said U.S.-China talks on trade and AI were 'very successful' ahead of President Trump's meeting with Xi Jinping. The discussions operationalized a Board of Trade and began work on AI. Xi is set to visit the White House this week after Trump's state visit to Beijing in May.
Washington ExaminerSig. 6OpinionHealthEconomyTrade
An op-ed argues that the Trump administration’s GLOBE and GUARD Medicare pilot programs, meant to stop foreign free-riding on U.S. drug prices, would instead penalize small and mid-size American biotech firms. Because those firms often out-license foreign marketing rights, the piece says they cannot control foreign pricing and would bear costs they cannot recover, potentially reducing innovation and patient access. It urges the administration to confront foreign governments directly rather than penalize U.S. innovators.
The HillSig. 8OpinionForeignTradeDefense
An opinion piece warns that Xi Jinping's Washington visit comes amid China's deep commercial penetration of U.S. infrastructure and key industries, arguing trade must be viewed through national security and enforcement lenses. It credits the Trump administration with accelerating a shift from decades of permissive trade policy to stricter scrutiny, while acknowledging the two economies remain intertwined.
Fox NewsSig. 5OpinionHealthEconomyTrade
This opinion piece argues that Trump's new drug pricing agreements are commendable but insufficient because the root cause of high U.S. drug prices is foreign governments free-riding on American pharmaceutical innovation. It urges the administration to target foreign price controls and rebate policies so other wealthy nations pay more for medicines.